Funding Opportunities

NIH Funding Opportunities

Clarifications to the NIH and AHRQ Policy for Application Submission
Notice NOT-OD-14-082 from the NIH Guide for Grants and Contracts
Tue, 22 Apr 2014 12:37:22 EST

Targeting Co-dependent Molecular Pathways in Oral Cancer (U01)
Funding Opportunity RFA-DE-15-004 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support multi-disciplinary projects aimed at the development of new targeted and effective therapies through systematic use and leveraging of recently identified genomic abnormalities and attendant changes in gene and/or protein expression profiles in human oral cancer samples. The goal of the FOA is the identification of co-dependent survival and proliferation pathways in oral cancer cells and the elucidation of potential signaling pathways that can be targeted with combination therapy approaches. This initiative requires collaboration of multi-disciplinary research teams that include cancer biologists, computational biologists, model system specialists and/or screening assay specialists. The emphasis will be on the conceptual phase of target identification and exploration including proof-of-concept phase.
Tue, 22 Apr 2014 09:36:28 EST

NEI Audacious Goal Initiative: Addressing Technical Needs and Opportunities for Imaging the Visual System (U01)
Funding Opportunity RFA-EY-14-001 from the NIH Guide for Grants and Contracts. The NEI Audacious Goal Initiative (AGI) strategic planning process (see http://www.nei.nih.gov/audacious) selected the single audacious goal (AG) of regenerating neurons and neural connections in the eye and visual system. This AG speaks to two conditions, loss of photoreceptor cells (PRC) by disease or injury and damage to retinal ganglion cells (RGC) as occurs in glaucoma or optic neuropathy. The AGI process also identified two areas of high programmatic priority, developing new treatments for eye disease using molecular approaches and understanding the intersection of aging and the biologic mechanisms of eye disease.
Wed, 23 Apr 2014 11:23:37 EST

Predoctoral Training in Biomedical Big Data Science (T32)
Funding Opportunity RFA-HG-14-004 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for graduate training programs in Big Data Science, for the expressed purpose of training the next generation of scientists who will develop computational and quantitative approaches and tools needed by the biomedical research community to work with biomedical Big Data in the biomedical sciences (see definition under Funding Opportunity Description). This proposed training initiative should prepare qualified individuals for careers in developing new technologies and methods that will allow biomedical researchers to maximize the value of the growing volume and complexity of biomedical data.
Tue, 22 Apr 2014 09:45:24 EST

Revisions to Add Biomedical Big Data Training to Active Institutional Training Grants (T32)
Funding Opportunity RFA-HG-14-005 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit revisions (competitive supplements) to add a Big Data Science track to currently funded T32 institutional training grants for the expressed purpose of training the next generation of scientists who will develop computational and quantitative approaches and tools needed by the biomedical research community to work with biomedical Big Data in the biomedical sciences (see definition under Funding Opportunity Description). This proposed training initiative should prepare qualified individuals for careers in developing new technologies and methods that will allow biomedical researchers to maximize the value of the growing volume and complexity of biomedical data.
Tue, 22 Apr 2014 09:45:18 EST

Revisions to Add Biomedical Big Data Training to Active NLM Institutional Training Grants in Biomedical Informatics (T15)
Funding Opportunity RFA-HG-14-006 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit revisions (competitive supplements) to add a Big Data Science track to active T15 institutional training grants for the expressed purpose of training the next generation of scientists who will develop computational and quantitative approaches and tools needed by the biomedical research community to work with biomedical Big Data in the biomedical sciences (see definition under Funding Opportunity Description). This proposed training initiative should prepare qualified individuals for careers in developing new technologies and methods that will allow biomedical researchers to maximize the value of the growing volume and complexity of biomedical data.
Tue, 22 Apr 2014 09:45:13 EST

NINDS Program Project Grant (P01)
Funding Opportunity PAR-14-183 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) is issued to enable submission of program project grant applications that propose to conduct innovative, interactive, high impact research.Applications should address significant scientific questions that are important for the mission of NINDS, via a synergistic collaboration between outstanding scientists who might not otherwise collaborate. The program project grant is designed to support research in which the funding of several interdependent highly meritorious projects as a group offers significant scientific advantages over support of these same projects as individual research grants.
Mon, 21 Apr 2014 11:42:56 EST

National Cooperative Drug Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (U01)
Funding Opportunity PAR-14-184 from the NIH Guide for Grants and Contracts. The purpose of the National Cooperative Drug Discovery/Development Group (NCDDG) Program is to create multidisciplinary research groups or partnerships for the discovery of pharmacological agents to treat and to study mental illness, drug or alcohol addiction. The objectives of this program are to: accelerate innovative drug discovery; develop pharmacologic tools for basic and clinical research on mental disorders, or drug or alcohol addiction; develop and validate tools in support of experimental therapeutic studies of innovative new candidates for mental disorders; and support early phase human clinical testing to rapidly assess the safety and efficacy of promising drug candidates and new indications for IND-ready agents for the treatment of mental disorders or alcohol addiction. This FOA encourages applications to advance the discovery, preclinical development, and proof of concept testing of new, rationally based candidate agents to treat mental disorders or drug or alcohol addiction, and to develop novel ligands as tools to further characterize existing or to validate new drug targets. Partnerships between academia and industry are strongly encouraged.
Mon, 21 Apr 2014 12:17:36 EST

Enabling Resources for Pharmacogenomics (R24)
Funding Opportunity PAR-14-185 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to support critical enabling resources that will accelerate new research discoveries and/or implementation of research discoveries in pharmacogenomics. A proposed resource must meet an ascertained community demand and benefit the entire scientific field of users. The FOA will support activities that can be clearly and specifically defined, are optimally designed, have evaluative measures built-in, are judiciously staffed, have formed partnerships where appropriate, and ideally have a proven track record and a finite lifetime. The outcome of an enabling resource must be highly impactful in a demonstrable way. Advance consultation with Scientific/Research staff to ensure that a proposed resource fits well with this opportunity is highly encouraged.
Tue, 22 Apr 2014 09:23:58 EST

NIDA Core "Center of Excellence" Grant Program (P30)
Funding Opportunity PAR-14-186 from the NIH Guide for Grants and Contracts. NIDA Core Center of Excellence Grants (P30) are intended to bring together investigators currently funded by NIH or other Federal or non-Federal sources, to enhance the effectiveness of existing research and also to extend the focus of research to drug abuse and addiction. It is expected that a Center will transform knowledge in the sciences it is studying. Incremental work should not be the focus of Center activities; rather, new and creative directions are encouraged. A P30 should integrate and promote research in existing funded projects, to achieve new and creative directions. It is expected that individual core activities reflect a relationship to the integrating theme of the Center and the Center is expected to support the education, training, and mentoring of new investigators, and share findings, data and their resources.
Wed, 23 Apr 2014 09:20:05 EST

Revision Applications for NIDCR-funded Cooperative Agreements (U01)
Funding Opportunity PAR-14-187 from the NIH Guide for Grants and Contracts. This FOA provides a mechanism for the submission of revision applications for active, NIDCR-funded U01 awards. The NIDCR uses the U01 Cooperative Agreement funding mechanism for a variety of projects requiring significant input from and oversight by NIDCR program staff. Although some requests for expansion/redirection of a project that are considered within the scope of the original specific aims can be handled administratively, more substantial changes in direction and increases in funding require peer review.
Wed, 23 Apr 2014 09:48:11 EST